RAS and PP2A activities converge on epigenetic gene regulation
Life Science Alliance · 2023
DOI: 10.26508/lsa.202301928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2023. Verfasst von Anna Aakula und 9 weiteren Autor:innen. Beteiligte Einrichtung: Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. Hauptthemen laut MEDLINE: DNA Methylation, Epigenesis, Genetic, Gene Expression Regulation, ras Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Ida Montin Foundation, Paulo Foundation.
Abstract (Originalsprache)
RAS-mediated human cell transformation requires inhibition of the tumor suppressor protein phosphatase 2A (PP2A). However, the phosphoprotein targets and cellular processes in which RAS and PP2A activities converge in human cancers have not been systematically analyzed. Here, we discover that phosphosites co-regulated by RAS and PP2A are enriched on proteins involved in epigenetic gene regulation. As examples, RAS and PP2A co-regulate the same phosphorylation sites on HDAC1/2, KDM1A, MTA1/2, RNF168, and TP53BP1. We validate RAS- and PP2A-elicited regulation of HDAC1/2 chromatin recruitment, of RNF168-TP53BP1 interaction, and of gene expression. Consistent with their known synergistic effects in cancer, RAS activation and PP2A inhibition resulted in epigenetic reporter derepression and activation of oncogenic transcription. Transcriptional derepression by PP2A inhibition was associated with an increase in euchromatin and a decrease in global DNA methylation. Collectively, the results indicate that epigenetic protein complexes constitute a significant point of convergence for RAS hyperactivity and PP2A inhibition in cancer. Furthermore, the work provides an important resource for future studies focusing on phosphoregulation of epigenetic gene regulation in cancer and in other RAS/PP2A-regulated cellular processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
- Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
- Structural Genomics Consortium, University of Toronto, Toronto, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Canada.
ORCID-Profile: Mukund Sharma, Reetta Nätkin, Jukka Westermarck
Förderung
- Academy of Finland
- Ida Montin Foundation
- Paulo Foundation
- Jane and Aatos Erkko Foundation
- EUbOPEN
Zitieren
APA
Aakula, A., Sharma, M., Tabaro, F., Nätkin, R., Kamila, J., Honkanen, H., Schapira, M., Arrowsmith, C., Nykter, M., & Westermarck, J. (2023). RAS and PP2A activities converge on epigenetic gene regulation. Life Science Alliance. https://doi.org/10.26508/lsa.202301928
Vancouver
Aakula A, Sharma M, Tabaro F, Nätkin R, Kamila J, Honkanen H, et al. RAS and PP2A activities converge on epigenetic gene regulation. Life Science Alliance. 2023. doi:10.26508/lsa.202301928
BibTeX
@article{Aakula2023,
author = {Aakula, Anna and Sharma, Mukund and Tabaro, Francesco and Nätkin, Reetta and Kamila, Jesse and Honkanen, Henrik and Schapira, Matthieu and Arrowsmith, Cheryl and Nykter, Matti and Westermarck, Jukka},
title = {RAS and PP2A activities converge on epigenetic gene regulation},
journal = {Life Science Alliance},
year = {2023},
doi = {10.26508/lsa.202301928}
}
EUVIMED